19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero

First Page		Document Content
Date: 2018-02-11 19:58:19		19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero Add to Reading List Source URL: www.antisense.com.au Download Document from Source Website File Size: 46,58 KB Share Document on Facebook